Technology | Magnetic Resonance Imaging (MRI) | December 21, 2015

Philips Unveils First MRI Automated User Interface for MR Conditional Patient Exams

Technology supports healthcare professionals’ first-time-right imaging for patients with MR conditional implants

Philips, ScanWise Implant, MRI, MR conditional implants, RSNA 2015

December 21, 2015 — Philips Healthcare introduced ScanWise Implant, the industry’s first magnetic resonance imaging (MRI)-guided user interface and automatic scan parameter selection, at the 2015 Radiological Society of North America (RSNA) annual meeting. The interface is designed to help simplify the scanning of patients with MR conditional implants, such as knee and hip replacements, spine implants, pacemakers and implantable defibrillators. The new software helps users streamline exams and supports diagnostic confidence of this growing patient population.

MRI is a modality of choice for diagnosing conditions such as neurological disorders, cancer, and muscle, joint and back pain. These conditions are most prevalent in older patient populations, and the population with large joint replacements and implanted cardiac devices is expected to increase by about 70 percent over the next five years.

However, implants can create a number of challenges with MRI exams. For example, it is difficult for clinicians to understand and scan within the safety limits defined by each implant manufacturer. These limits are not always clear or easy to implement on the MR scanner, causing patients with MR conditional implants to often be denied MRI exams.

Introducing MRI to a patient’s diagnostic and treatment plan allows clinicians enhanced accuracy and improved workflow, and provides patients with access to better care. According to Harald Kugel, Ph.D., Department of Clinical Radiology, University of Münster, “The previous industry standard was: if patients had an implant, they couldn’t be examined with MR. However, patients deserve the best imaging modality available and shouldn’t be excluded from a modality, because risks aren’t truly known and documented. It’s a milestone achievement that Philips developed an answer for patients with conditional implants to have access to MRIs.”

“From a technologist’s perspective, we’re excited about the prospect of shortening exam times and broadening the diagnostic modalities available for those patients with MR conditional implants,” said Scott Hipko, chief MRI research technologist, The University of Vermont, College of Medicine. “Philips understands the needs of radiologists and brings the expertise needed to create a smart solution to help guide operators to meet the specific criteria for each implant.”

ScanWise Implant is the newest addition to Philips’ advanced diagnostic imaging solutions designed to support first-time-right imaging. Other products within this portfolio include:

  • Ingenia 1.5T S, which is designed for first-time-right imaging and increased patient comfort for a faster workflow;
  • mDIXON XD, which provides fast, sharp and fat-free imaging for all anatomies, increasing the diagnostic information by providing two contrasts in a single scan; and
  • Philips’ MR in-bore experience, which helps to improve the patient experience and utilizes AutoVoice and ComforTone to turn the patient exam into an event.

For more information: www.philips.com

Related Content

CZT SPECT camera detectors offered by GE.

A display of CZT SPECT gamma camera detectors at RSNA 2016. These detectors are more sensitive than those used in older cameras, allowing for faster scans or lower radiation dose. 

Feature | Nuclear Imaging| September 19, 2017 | Dave Fornell
Cardiac nuclear myocardial perfusion imaging (MPI) has been a mature area of imaging for years, but has recently star
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging| September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Orange County, Calif. Hospital Adopts Siemens Somatom Force CT for Cardiac Imaging
News | Computed Tomography (CT)| September 12, 2017
Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif., to install the Siemens...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
Overlay Init